Erevna Innovations Inc.
21
6
8
13
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
0.0%
0 terminated/withdrawn out of 21 trials
100.0%
+13.5% vs industry average
52%
11 trials in Phase 3/4
0%
0 of 13 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (21)
Topical Multivitamin Serum for Skin Heath
Role: lead
Microneedling for Skin Heath
Role: lead
Aesthetic Improvement of Facial Rhytids Using Injectables
Role: lead
Post-Menopause Skin Rejuvenation Study
Role: lead
Hyaluronic Acid Filler Migration
Role: lead
PLLA and CaHA-R for Aesthetic Rejuvenation
Role: lead
New Technique and Product for Chin Enhancement
Role: lead
Pan-Facial Layering of Hyaluronic Acid Filler
Role: lead
Kiss and Smile HIT (Holistic Individualized Treatment)
Role: lead
"Profile HIT" (Holistic Individualized Treatment)
Role: lead
Restylane Shaype Versus Juvederm Volux for Chin Augmentation
Role: lead
Comparing Injections With Poly-L-Lactic Acid in the Temporal Fossa vs. Extended Temporal Fossa + Hairline
Role: lead
Safety and Efficacy of Fillers for Contouring the Jawline
Role: lead
RADIESSE Injection in Perioral and Marionette Lines
Role: lead
Restylane® Skinboosters™ Vital in the décolletage Region
Role: lead
Restylane® for the Treatment of Tear Trough Deformity
Role: lead
Efficacy and Safety of Poly-L-lactic Acid
Role: lead
Restylane + Lidocaine and Restylane Lyft for the Treatment of Nasolabial Folds
Role: lead
Midfacial Product Selection
Role: lead
Evaluation of Physician Volumetric Accuracy During Filler Injections
Role: lead